Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders
Hepatitis Monthly · 09.02.2020 · 20 (2)
DOI: 10.5812/hepatmon.95101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Monthly, online erschienen am 09.02.2020. Verfasst von Andrea Marino und 11 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Marino, A., Scuderi, D., Locatelli, M. E., Gentile, A., Pampaloni, A., Cosentino, F., Ceccarelli, M., Celesia, B. M., Benanti, F., Nunnari, G., Montineri, A., & Cacopardo, B. (2020). Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders. Hepatitis Monthly, 20(2). https://doi.org/10.5812/hepatmon.95101
Vancouver
Marino A, Scuderi D, Locatelli ME, Gentile A, Pampaloni A, Cosentino F, et al. Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders. Hepatitis Monthly. 2020;20(2). doi:10.5812/hepatmon.95101
BibTeX
@article{Marino2020,
author = {Marino, Andrea and Scuderi, Daniele and Locatelli, Maria Elena and Gentile, Adele and Pampaloni, Alessio and Cosentino, Federica and Ceccarelli, Manuela and Celesia, Benedetto Maurizio and Benanti, Francesco and Nunnari, Giuseppe and Montineri, Arturo and Cacopardo, Bruno},
title = {Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders},
journal = {Hepatitis Monthly},
year = {2020},
volume = {20},
number = {2},
doi = {10.5812/hepatmon.95101}
}
EUVIMED